Keyphrases
Brainstem Glioma
100%
Tenascin-C
100%
Brainstem
100%
Therapeutic Target
100%
Tissue Specimens
75%
Gli1
75%
GSK-J4
50%
Mutation Status
50%
Shh Signaling Pathway
50%
Histone H3
50%
Cyclopamine
50%
Cell Lysate
50%
Molecular Profiling
50%
Histone 3 Gene
50%
Notch2
50%
Quantitative PCR
50%
Tumor
50%
MRNA Expression
50%
Genetic Modification
50%
Glioma
50%
Inhibiting Effect
25%
Gene Transfer
25%
Downstream Effects
25%
Gene Promoter Methylation
25%
Functional Studies
25%
H3K27M
25%
SHH Inhibitors
25%
Property Effects
25%
Co-expression
25%
Identified Genes
25%
Expression Quantification
25%
Exogenous Gene
25%
Control Specimen
25%
Pathway Genes
25%
HIST1H3B
25%
SOX4
25%
FACS Sorting
25%
SiRNA Knockdown
25%
Tumorigenesis
25%
Demethylase
25%
Biological Properties
25%
Cell Survival
25%
Gene Expression
25%
Cell Population
25%
Pathway Activation
25%
Molecular Mechanism
25%
Serum Samples
25%
Commercially Available
25%
Cell Migration
25%
Putative Drug Targets
25%
Integrin
25%
Western Blot
25%
Immunohistochemical Staining
25%
Tumor Growth
25%
Overexpressing
25%
Methylation Status
25%
Cell Proliferation
25%
Expression Level
25%
Xenograft
25%
Treatment Effect
25%
Medicine and Dentistry
Pediatrics
100%
Tenascin
100%
Brainstem Glioma
100%
Brainstem
100%
Histone H3
100%
Ganglioglioma
50%
In Vitro
50%
Reverse Transcription Polymerase Chain Reaction
50%
Molecular Profiling
50%
Neoplasm
50%
Cyclopamine
50%
Cell Line
50%
Messenger RNA
50%
Xenograft
25%
Upregulation
25%
Cell Population
25%
Carcinogenesis
25%
Gene Expression
25%
Epidermal Growth Factor Receptor
25%
Cell Survival
25%
Cell Proliferation
25%
Tumor Progression
25%
Small Interfering RNA
25%
Gene Promoter
25%
Gene Transfer
25%
Cell Migration
25%
Fluorescence Activated Cell Sorting
25%
Methylation
25%
Western Blot
25%
Integrin
25%